Streetbeat News

Stock Prices

TXG

10x Genomics (NYSE:TXG) has seen a 4.71% decrease in its short percent of float, now at 8.1% of available shares. This is higher than its peers' average of 5.21%. The decrease in short interest may indicate a shift towards a more bullish sentiment.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 2:00 pm

SPY

The NAHB Housing Market Index for October remained steady at 43, matching expectations and showing no change from the previous month. This indicates a stable sentiment in the housing market.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 2:00 pm

IQV

IQVIA Holdings (NYSE:IQV) has seen a 3.48% decrease in its short percent of float, now at 1.94%. This is lower than its peers' average of 5.46%. The decrease in short interest may indicate a more bullish sentiment among investors.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 2:00 pm

LXRX

Lexicon Pharmaceuticals (NASDAQ:LXRX) has been evaluated by 8 analysts over the past three months, with all ratings being bullish. The average 12-month price target remains at $10.00. Despite strong revenue growth, the company faces challenges with profitability and returns on equity and assets.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 2:00 pm

SPY

The USA Business Inventories for August increased by 0.3%, matching both the estimate and the prior month's figure.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 2:00 pm

NUZE

NuZee shares are trading higher following the announcement of relocating its U.S. operations from California to Florida to enhance its global business development.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:58 pm

AA

ATNF

BREA

DUO

NIXX

STAF

STEC

U.S. stocks rose with the Dow Jones gaining over 100 points. Alcoa Corporation reported better-than-expected earnings, boosting its stock. Staffing 360 Solutions, Nixxy, and Brera Holdings saw significant stock price increases, while Santech Holdings, 180 Life Sciences, and Fangdd Network Group experienced declines.

Portfolio Pulse from Avi Kapoor

October 17, 2024 | 1:57 pm

BDRX

Bioedexa Pharmaceuticals shares are trading lower following the release of patient updates from the MAGIC-1 study of MTX110 in recurrent Glioblastoma, which reported on progression-free survival and overall survival.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:56 pm

VSTM

Verastem's shares are declining following the presentation of updated data on their Avutometinib and Defactinib combination treatment for recurrent low-grade serous ovarian cancer at IGCS 2024.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:53 pm

CMC

Commercial Metals Company (CMC) reported a slight beat on Q4 EPS but missed revenue expectations. The company anticipates a challenging start to fiscal 2025 due to macroeconomic uncertainties and weaker sentiment in the construction industry. Despite stable demand in North America, European operations faced losses. CMC's strategic initiatives aim for long-term value creation.

Portfolio Pulse from Akanksha Bakshi

October 17, 2024 | 1:52 pm